The Valley Desk

NCT06395090 · Interventional trial

A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)

Overall registry status Withdrawn

Phase 1 · Phase 2

Conditions Neoplasm Metastasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov